(Q34150295)

31 July 2017

title

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report (English)

1 reference

chronic spontaneous urticaria

31 July 2017

1 reference

1 reference

17

T Zuberbier

1 reference

31 July 2017

Giorgio Walter Canonica

7

object named as

G W Canonica

1 reference

31 July 2017

Carsten Bindslev-Jensen

3

object named as

C Bindslev-Jensen

1 reference

31 July 2017

11

M W Greaves

1 reference

31 July 2017

1

M Maurer

1 reference

31 July 2017

K Weller

2

1 reference

31 July 2017

A Giménez-Arnau

4

1 reference

31 July 2017

P J Bousquet

5

1 reference

31 July 2017

J Bousquet

6

1 reference

31 July 2017

M K Church

8

1 reference

31 July 2017

K V Godse

9

1 reference

31 July 2017

C E H Grattan

10

1 reference

31 July 2017

M Hide

12

1 reference

31 July 2017

D Kalogeromitros

13

1 reference

31 July 2017

A P Kaplan

14

1 reference

31 July 2017

S S Saini

15

1 reference

31 July 2017

X J Zhu

16

1 reference

31 July 2017

publication date

17 November 2010

1 reference

31 July 2017

1 reference

31 July 2017

volume

66

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

317-330

1 reference

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Hay fever, eczema and urticaria in southwest Norway. Lifetime prevalences and association with sex, age, smoking habits, occupational airborne exposures and respiratory symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Epidemiology of urticaria: a representative cross-sectional population survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Natural course of physical and chronic urticaria and angioedema in 220 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Chronic idiopathic urticaria: prevalence and clinical course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Chronic urticaria. Evaluation of the role of physical, immunologic, and other contributory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Urticaria and angio-oedema. A review of 554 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Autologous Whole Blood Injections to Patients with Chronic Urticaria and a Positive Autologous Serum Skin Test: A Placebo-Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Neuroimmunology of stress: skin takes center stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

The relationship between posttraumatic stress disorder, psychiatric comorbidity, and personality traits among patients with chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Stress, psychiatric co-morbidity and coping in patients with chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Effects of relaxation therapy and hypnotizability in chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Treatment of urticaria and severe headache by behavior therapy. A case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

10 years experience of the Dermatology Life Quality Index (DLQI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Clinical characteristics of pruritus in chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Insomnia: epidemiology, characteristics, and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Psychiatric morbidity in dermatological outpatients: an issue to be recognized.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Axis I and Axis II diagnoses in patients with chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Quality of life in patients with chronic idiopathic urticaria: the impact of Axis I and Axis II psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

21 January 2018

Urticaria: then and now.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Treatment of chronic autoimmune urticaria with omalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Effect of omalizumab on patients with chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Treatment of chronic idiopathic urticaria with levamisole: a multicentre, randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Chronic idiopathic urticaria: Comparison of the clinical features of patients with and without anti-FcϵRI or anti-IgE autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

Reactivity to autologous serum skintest and clinical features in chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2010.02496.X

10.1111/J.1398-9995.2010.02496.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference